Company news: CSL Behring and McGraw-Hill

Share this article:
CSL Behring awarded advocacy grants worth around $100,000 to six patient groups through its Local Empowerment for Advocacy Development program, which supports groups helping patients using plasma-derived or recombinant therapies for rare and serious diseases, including bleeding disorders, immune deficiencies and hereditary angioedema.

McGraw-Hill launched mobile versions of its AccessMedicine and AccessPharmacy sites for healthcare professionals. The publisher currently supports iPhone and iPhone 3G, Android and BlackBerry Bold.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions